Cover Stories

Cover Stories

An in-depth look at trends and controversies in hematology and oncology.

Cover Story

AI an emerging tool, not substitute, for oncologists

HemOnc Today, August 25, 2019
Advances in artificial intelligence technology and deep learning algorithms are leading the way to more timely and accurate cancer diagnoses, with…
Cover Story

BCG: a real-world example of health care rationing

HemOnc Today, August 10, 2019
Bacillus Calmette-Guérin, or BCG, is highly effective at treating and preventing recurrence of early-stage bladder cancer. BCG is a strain of…
Cover Story

Aggressive end-of-life care: A disservice to patients

HemOnc Today, July 25, 2019
The availability of more effective and less toxic anticancer agents has made it increasingly difficult for clinicians to discern when to discontinue…
Cover Story

Driving Killer CARs into Cancer

Cell Therapy Next, July 2019
Automobile pioneer Henry Ford once said of his best-selling Model T, “Any customer can have a car painted any color that he wants so long as…
Cover Story

New treatments, new outcomes for refractory thyroid cancer

HemOnc Today, July 10, 2019
Thyroid cancer diagnoses are increasing rapidly in the United States. But, with an estimated incidence of four cases per million population, thyroid…
Cover Story

Despite promising new regimens, search for cure is ‘highest priority’ in advanced renal cell carcinoma

HemOnc Today, June 25, 2019
With approximately 73,820 diagnoses and 14,770 deaths expected this year in the U.S., renal cell carcinoma remains a cancer in need of new treatment…
Cover Story

Sickle cell disease poised for ‘golden age of treatment’ amid progress toward cure

HemOnc Today, June 10, 2019
As researchers work to expand curable approaches for sickle cell disease, new options for managing its acute and chronic complications appear within…
Cover Story

‘A Moment of Marvel’ in Manhattan Brings a Revolution in CAR T-Cell Therapy

Cell Therapy Next, May 2019
When the first flow cytometry analysis was run after a CAR T-cell therapy, showing no evidence of leukemia, Michel Sadelain, MD, PhD, and Isabelle
Cover Story

Efforts to reduce racial disparities in cancer care aim to ‘make the invisible visible’

HemOnc Today, May 25, 2019
The trends are clear — not only do ethnic and racial minority groups face poorer cancer outcomes, they also are less frequently invited to…
Cover Story

Venous thromboembolism guidelines aim to clarify proper care in areas with ‘a lot of uncertainty’

HemOnc Today, May 10, 2019
Venous thromboembolism — which includes deep vein thrombosis and pulmonary embolism — causes up to 100,000 deaths annually in the United…